Treatment of endometriosis with transvaginal ultrasound-guided drainage and recombinant interleukin-2 left in the cysts: A third clinical trial

Gynecologic and Obstetric Investigation

Volumn 69, Issue 3, 2010, Pages 203-211

  Acién, Pedro ^a   Velasco, Irene ^a   Acién, Maribel ^a   Quereda, Francisco ^a  

^a MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

Author keywords

Drainage; Endometriomas; GnRH analogues; Immunomodulators; Recombinant interleukin 2; Treatment

Indexed keywords

CA 125 ANTIGEN; RECOMBINANT INTERLEUKIN 2;

ADULT; ARTICLE; ASPIRATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; ENDOMETRIOSIS; ENDOMETRIUM TUMOR; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LAPAROSCOPIC SURGERY; LAPAROTOMY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUNCTURE; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SURGICAL DRAINAGE; TRANSVAGINAL ECHOGRAPHY; TUMOR VOLUME;

ADULT; COMBINED MODALITY THERAPY; DRAINAGE; ENDOMETRIOSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOLOGIC FACTORS; INJECTIONS, INTRALESIONAL; INTERLEUKIN-2; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; RECURRENCE; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL; YOUNG ADULT;

EID: 73249127586     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000270901     Document Type: Article

References (35)

1. Hill JA: Immunology and endometriosis. Fertil Steril 1992; 58: 262-264.
2. Braun DP, Dmowski WP: Endometriosis: abnormal endometrium and dysfunctional immune response. Curr Opin Obstet Gynecol 1998; 10: 365-369.
3. Tariverdian N, Theoharides TC, Siedentopf F, Gutiérrez G, Jeschke U, Rabinovich GA, Blois SM, Arck PC: Neuroendocrine-immune disequilibrium and endometriosis: an interdisciplinary approach. Semin Immunopathol 2007; 29: 193-210.
4. Braun DP, Gebel H, Rotman C, Rana N, Dmowski WP: The development of cytotoxicity in peritoneal macrophages from women with endometriosis. Fertil Steril 1992; 57: 1203-1210.
5. Melioli G, Semino C, Semino A, Venturini PL, Ragni N: Recombinant interleukin-2 corrects in vitro the immunological defect of endometriosis. Am J Reprod Immunol 1993; 30: 218-227.
6. D'Hooghe TM: Immunomodulators and aromatase inhibitors: are they the next generation of treatment for endometriosis? Curr Opin Obstet Gynecol 2003; 15: 243-249.
7. Giorlandino C, Taramanni C, Muzii L, Santillo E, Nanni C, Vizzone A: Ultrasoundguided aspiration of ovarian endometriotic cysts. Int J Gynaecol Obstet 1993; 43: 41-44.
8. Zanetta G, Lissoni A, Dalla Valle C, Trio D, Pittelli M, Rangoni G: Ultrasound-guided aspiration of endometriomas: possible applications and limitations. Fertil Steril 1995; 64: 709-713.
9. Fisch JD, Sher G: Sclerotherapy with 5% tetracycline is a simple alternative to potentially complex surgical treatment of ovarian endometriomas before in vitro fertilization. Fertil Steril 2004; 82: 437-441.
10. Donnez J, Nisolle M, Gillerot S, Anaf V, Clerks-Braun F, Casanas-Roux F: Ovarian endometrial cysts: the role of gonadotropinreleasing hormone agonists and/or drainage. Fertil Steril 1994; 62: 63-66.
11. Muzii L, Marana R, Caruana P, Catalano GF, Mancuso S: Laparoscopic findings after transvaginal ultrasound-guided aspiration of ovarian endometriomas. Hum Reprod 1995; 10: 2902-2903.
12. Chan LY, So WW, Lao TT: Rapid recurrence of endometrioma after transvaginal ultrasound-guided aspiration. Eur J Obstet Gynecol Reprod Biol 2003; 109: 196-198.
13. Agostini A, De Lapparent T, Collette E, Capelle M, Cravello L, Blanc B: In situ methotrexate injection for treatment of recurrent endometriotic cysts. Eur J Obstet Gynecol Reprod Biol 2007; 130: 129-131.
14. Acién P, Quereda FJ, Gómez-Torres MJ, Bermejo R, Gutierrez M: GnRH analogues, transvaginal ultrasound-guided drainage and intracystic injection of recombinant interleukin-2 in the treatment of endometriosis. Gynecol Obstet Invest 2003; 55: 96-104.
15. Acién P, Pérez-Albert G, Quereda FJ, Sanchez-Ferrer M, García-Almela A, Velasco I: Treatment of endometriosis with transvaginal ultrasound-guided drainage under GnRH analogues and recombinant interleukin-2 left in the cysts. Gynecol Obstet Invest 2005; 60: 224-231.
16. Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, et al: Improving the quality of reporting of randomised controlled trials. The CONSORT statement. JAMA 1996; 276: 637-639.
17. Ingelmo JMR, Quereda F, Acién P: Intraperitoneal and subcutaneous treatment of experimental endometriosis with recombinant human interferon- 2b in murine model. Fertil Steril 1999; 71: 907-911.
18. Acién P, Quereda F, Campos A, Gómez-Torres MJ, Velasco I, Gutierrez M: Use of intraperitoneal interferon-alfa 2b therapy after conservative surgery for endometriosis and postoperative medical treatment with depot gonadotropin-releasing hormone analogue: a randomised clinical trial. Fertil Steril 2002; 78: 705-711.
19. Garzetti GG, Ciavattini A, Provinciali M, Muzzioli M, Di Stefano G, Fabris N: Natural killer activity in stage III and IV endometriosis: impaired cytotoxicity and retained lymphokine responsiveness of natural killer cells. Gynecol Endocrinol 1995; 9: 125-130.
20. Somigliana E, Vigano P, Rossi G, Carinelli S, Vignali M, Panina-Bordignon P: Endometrial ability to implant in ectopic sites can be prevented by interleukin-12 in a murine model of endometriosis. Hum Reprod 1999; 14: 2944-2950.
21. Loh FH, Bongso A, Fong CY, Koh DR, Lee SH, Zhao HQ: Effects of peritoneal macrophages from women with endometriosis on endometrial cellular proliferation in an in vitro coculture model. Fertil Steril 1999; 72: 533-538.
22. Bertoglio S, Melioli G, Baldini E, Catturich A, Sertoli MR, Civalleri D, et al: Intraperitoneal infusion of recombinant interleukin-2 in malignant ascites in patients with gastrointestinal and ovarian cancer. Acta Med Austriaca 1989; 16: 81-83.
23. Ferlazzo G, Magno C, Lupo G, Rizzo M, Iemmo R, Semino C, Melioli G: A phase I study of intravesical continuous perfusion of recombinant interleukin-2 patients with superficial bladder cancer. Am J Clin Oncol 1995; 18: 100-104.
24. Ferlazzo G, Scisca C, Iemmo R, Cavaliere R, Quartarone G, Adamo V, et al: Intralesional sonographically guided injections of lymphokine-activated killer cells and recombinant interleukin-2 for the treatment of liver tumors: a pilot study. J Immunother 1997; 20: 158-163.
25. Meldrum VR, Chang RJ, Lu J, Vale W, Rivier J, Judd HL: Medical ovariectomy using a long-acting GnRH agonist: a possible new approach to the treatment of endometriosis. J Clin Endocrinol Metab 1982; 54: 1081-1083.
26. Quereda F, Barroso J, Acién P: Individual and combined effects of triptoreline and gestrinone on experimental endometriosis in rats. Eur J Obstet Gynecol Reprod Biol 1996; 67: 35-40.
27. Badawy SZA, Cuenca V, Kumar S, Holland J: Effects of chocolate cyst fluid on endometrioma cell growth in culture. Fertil Steril 1998; 70: 827-830.
28. Hsieh CL, Shiau CS, Lo LM, Hsieh TT, Chang MY: Effectiveness of ultrasoundguided aspiration and sclerotherapy with 95% ethanol for treatment of recurrent ovarian endometriomas. Fertil Steril 2009; 91: 2709-2713.
29. Mesogitis S, Antsaklis A, Daskalakis G, Papantoniou N, Michalas S: Combined ultrasonographically guided drainage and methotrexate administration for treatment of endometriotic cysts. Lancet 2000; 355: 1160.
30. Creus M, Fábregues F, Carmona F, del Pino M, Manau D, Balasch J: Combined laparoscopic surgery and pentoxifylline therapy for treatment of endometriosis-associated infertility: a preliminary trial. Hum Reprod 2008; 23: 1910-1916.
31. Kamencic H, Thiel JA: Pentoxifylline after conservative surgery for endometriosis: a randomized, controlled trial. J Minim Invasive Gynecol 2008; 15: 62-66.
32. Uygur D, Aytan H, Zergeroglu S, Batioglu S: Leflunomide - an immunomodulator induces regression of endometrial explants in a rat model of endometriosis. J Soc Gynecol Investig 2006; 13: 378-383.
33. Laschke MW, Elitzsch A, Scheuer C, Holstein JH, Vollmar B, Menger MD: Rapamycin induces regression of endometriotic lesions by inhibiting neovascularization and cell proliferation. Br J Pharmacol 2006; 149: 137-144.
34. Sel'kov SA, Pavlov RV: Comparative efficiency of intraperitoneal interleukin-2 and interferon-A in rats with experimental endometriosis. Bull Exp Biol Med 2007; 143: 363-367.
35. D'Hooghe TM, Kyama CK, Mihalyi AM, Chai D, Falconer H, Mwenda JM: The baboon model for translational research in endometriosis. Reprod Sci 2009; 16: 152-161.